Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-21-068134

Chief Commercial Officer bought 35,200 shares at $1.34 ($47,168)

From the SEC's structured data for this filing

Trades in this filing

Evanson Jeff · Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-12-03 Purchase : show line 1 in the form +35,200 $1.34 $47,168 1,177,130 D
Open-market purchases · 35,200 sh · avg $1.34 · $47,168
Loading xslF345X03/doc4.xml…